Daniel Pap, MD
Interventional Pain Medicine · New Albany, OHNPI 1306136429
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $478 and has fallen 69.9% since, to $144 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in OH, where the typical reported total is $5,193.
Across 54 payments — averaging $39.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$310
- Medtronic$305
- Impel Pharmaceuticals Inc.$226
- Boston Scientific$217
- Pfizer$175
- Stryker$160
- plus $757 from 10 others
What the payments were for
- Food & beverage$2,150100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 3 | $310 |
| Medtronic(2 entities) | 6 | $305 |
| Impel Pharmaceuticals Inc. | 2 | $226 |
| Boston Scientific | 6 | $217 |
| Pfizer | 20 | $175 |
| Stryker | 2 | $160 |
| CDC Medical LLC | 1 | $156 |
| Abbott | 4 | $144 |
| Si-bone, Inc. | 2 | $143 |
| Biohaven Pharmaceuticals, Inc. | 1 | $87 |
| Nalu Medical, Inc. | 2 | $81 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $37 |
| Eli Lilly | 1 | $33 |
| Nevro Corp. | 1 | $31 |
| Pacira Pharmaceuticals Incorporated | 1 | $29 |
| Bioventus LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$232
- Trudhesa$226
- OPTABLATE$144
- iFuse Implant$130
- INTELLIS$115
How this compares
$2,150 in reported general payments places this provider in the 25th percentile of 67 interventional pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 313 | $2,370 |
| Methylprednisolone | 213 | $1,379 |
| Methocarbamol | 248 | $955 |
| Nortriptyline Hcl | 142 | $745 |
| Duloxetine Hcl | 70 | $718 |
| Tizanidine Hcl | 98 | $650 |
| Pregabalin | 39 | $485 |
| Meloxicam | 117 | $216 |
| Diclofenac Sodium | 38 | $197 |
| Cyclobenzaprine Hcl | 15 | $77 |
| Baclofen | 14 | $35 |
| Alprazolam | 11 | $7 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in New Albany
- Junaid MukhdomiNew Albany$18K
- Marcus HarrisNew Albany$9K
- Gladstone McDowellColumbus$660K
- Humam AkbikFairfield$116K
- Sara NashiCincinnati$116K
- Jaudat MahmoodKent$97K
- Omar AliSpringfield$67K
- Dustin ReynoldsWesterville$61K
- James OttingToledo$47K
- Mark MalinowskiChillicothe$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.